We have developed a breakthrough phototherapy for wound treatment. Our technology enables annihilation of microbes without concern for antimicrobial resistance. We have received NIH funding for our research.

• Unmet need: killing of microbes without concern for antimicrobial resistance
• Technology: inactivate microbes’ defenses against reactive oxygen species
• Supporting data: in vitro and in vivo studies
• Intellectual property: 2 issued US patents and 10 pending US and international patent applications
• Regulatory: preparing Pre-Submission to FDA
• Clinical Study: Pulsethera’s technology combined with standard of care for pressure ulcers